New trial finds first-ever Alzheimer's drug to slow cognitive decline
Pharmaceutical companies Eisai and Biogen have announced the first results from a Phase 3 human trial testing a drug designed to treat symptoms of dementia associated with Alzheimer's disease. The drug seems to be successful at slowing cognitive decline, making it the first drug to ever effectively...
https://newatlas.com/health-wellbeing/lecanemab-alzheimers-drug-slow-cognitive-decline-large-human-trial/